Does Florida Blue cover Wegovy? And Zepbound?

Coverage at a glance

Prior authorization: the plan reviews the prescription before it pays.

Florida Blue commercial plans exclude Wegovy, Zepbound and Saxenda for weight loss. They cover GLP-1 drugs only for type 2 diabetes. That comes from Florida Blue's own provider bulletin, in force since April 1, 2025. This answer covers Commercial fully insured and HMO plans. BlueChoice, BlueOptions, BlueSelect, BlueCare, myBlue, SimplyBlue and Truli for Health.

Source: Florida Blue Provider bulletin 119973 0125 (January 2025). Checked August 18, 2026.

Where your plan lists it. The September 2026 edition of Florida Blue's Care Choices medication guide does not list Wegovy or Zepbound. It puts Ozempic and Mounjaro on tier 5, the preferred brand tier on that seven-tier guide, and Florida Blue's medication guide page sends BlueOptions, BlueSelect and BlueCare members to Care Choices. Sources: Florida Blue Care Choices Medication Guide. Florida Blue, Medication guides for covered drugs. Checked September 6, 2026.

What it costs once they say yes. With commercial insurance the manufacturer savings card takes Wegovy or Zepbound to as little as $25 a month. Your plan sets the copay before the card applies. What Wegovy costs with your plan. What Zepbound costs with your plan.

If the weight-loss exclusion above applies to you, you are paying for this yourself.

Coverage by indication

Obstructive sleep apnea: the Florida Blue weight-loss drug policy names no separate route for it. Zepbound's FDA label carries the indication, so ask the plan which policy applies to it.

Ozempic, Mounjaro and Rybelsus on Florida Blue plans

Ozempic, Mounjaro and Rybelsus are approved for type 2 diabetes, not weight loss.

What to do next

If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.

• Browse the prior-authorization letter library for a template that matches your plan and indication.
• Read why plans say no and the four ways to appeal in the GLP-1 insurance guide.
• Your plan may treat another GLP-1 differently. The Florida Blue coverage check lists all 4, with the source for each.
• If the plan denies it, the appeal letter library has a template for each reason a plan gives. That covers the peer-to-peer call with a plan doctor, the Level 1 and Level 2 appeals inside the plan, and the outside review that follows them.
• Call the number on your insurance card and ask whether your specific plan includes the weight-management drug benefit before you submit.
• If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.

What it costs without insurance

The programs below bill you directly.

Frequently asked questions

Coverage for other payers

See the full payer coverage index for every plan we have sourced.

How we built this page

Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.

Written and edited by John SamarasAbout this siteContact